27 results
8-K
CLNN
Clene Inc
19 Sep 23
Departure of Directors or Certain Officers
8:22am
of the Nominating and Corporate Governance Committee of the Board, appointed Professor Matthew Kiernan AM, Ph.D., DSc, and Arjun (JJ) Desai, M.D., as members
424B3
seus3 e06e76ogavx
11 Aug 21
Prospectus supplement
4:01pm
424B3
l7s0kgl l8
11 Aug 21
Prospectus supplement
4:00pm
8-K
7ppivi
9 Aug 21
Clene Nanomedicine Appoints Dr. Vallerie McLaughlin to its Board of Directors
4:07pm
424B3
05l93vp3 zn38a
2 Aug 21
Prospectus supplement
5:03pm
424B3
r0c3 nfonh
12 May 21
Prospectus supplement
4:43pm
8-K
m6gkuhhbnc5vtkfdy 0x
22 Apr 21
Departure of Directors or Certain Officers
12:00am
424B3
pntdktlc5r87y2ry lw
21 Apr 21
Prospectus supplement
6:04am
DEF 14A
wol30p 9w
5 Apr 21
Definitive proxy
12:00am
10-K
ts33aj1owyenz7o73x
29 Mar 21
Annual report
12:00am
PRE 14A
22z6ngm
18 Mar 21
Preliminary proxy
4:33pm
S-1
kptbvut2
17 Feb 21
IPO registration
12:00am
8-K
1d44ivvfi61 oskfm3
5 Jan 21
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update
5:18pm
424B3
7ljwhnp u98cks
18 Dec 20
Prospectus supplement
2:24pm